USPTO Issues ‘Notice of Allowance’ for Company’s Patent Application, Boosts Development of New Treatments for Patients with Heart Failure
(PRWeb September 26, 2019)
Read the full story at https://www.prweb.com/releases/sarfez_completes_formulation_development_plans_clinical_trials_for_combination_of_loop_diuretic_and_sglt_2_inhibitor/prweb16595036.htm